1 – 7 of 7
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
    
    - Contribution to journal › Article
 
- 2017
- 
                        Mark
        FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
    
    - Contribution to journal › Article
 
- 
                        Mark
        Inflammatory Cells and Mediators in the Tumor Microenvironment of Breast Cancer
    (2017)- Thesis › Doctoral thesis (compilation)
 
- 2014
- 
                        Mark
        Investigation of molecular alterations of AKT-3 in triple-negative breast cancer
    
    - Contribution to journal › Article
 
